Aug 2026· Frontiers in Endocrinology· Vol 17· 0 citations· 39 references
Medicine
TL;DR
The METS-IR, TyG-BMI, and SPISE showed robust nonlinear associations with CKM syndrome risk and were stronger in males, supporting their potential value in sex-tailored risk assessment.
Abstract
Background Insulin resistance (IR) is a key driver of cardiovascular–kidney–metabolic (CKM) syndrome. This study evaluated the independent associations of three novel IR surrogate indices—the Metabolic Score for Insulin Resistance (METS–IR), Triglyceride–Glucose–Body Mass Index (TyG–BMI), and Single Point Insulin Sensitivity Estimator (SPISE)—with CKM syndrome risk and compared their predictive performance for short- and long-term outcomes. Methods This retrospective cohort study included 12,334 Chinese adults aged ≥20 years enrolled between 2015 and 2019. Multivariable logistic regression and restricted cubic splines were used for association assessment, while area under the receiver operating characteristic curve (AUROC) analysis was used to evaluate predictive accuracy. Subgroup analyses were performed for age, sex, and BMI. Results Analysis of 1- and 5-year follow-up outcomes revealed that the METS–IR and TyG–BMI were positively associated with CKM syndrome, whereas SPISE showed an inverse association (all p < 0.001). All indices exhibited nonlinear dose–response relationships. Adding each IR index separately to the base model improved discrimination: 1-year AUROC increased from 0.681 to 0.710–0.712 and 5-year AUROC from 0.719 to 0.737–0.741 (all p < 0.001). SPISE achieved the highest AUROC at both time points, pairwise comparisons with the other indices showed statistically significant differences of 0.002–0.003 (all p ≤ 0.033). Subgroup analyses indicated stronger associations in males and participants aged <40 years for short-term risk, with sex-specific effect modification for long-term outcomes. Conclusion The METS-IR, TyG-BMI, and SPISE showed robust nonlinear associations with CKM syndrome risk. Their overall discriminatory performance was broadly comparable, with SPISE showing a marginal advantage. The associations were stronger in males, supporting their potential value in sex-tailored risk assessment.
Cardiovascular–kidney–metabolic (CKM) syndrome integrates cardiovascular disease, chronic kidney disease, and metabolic risk factors, highlighting their interaction and shared progression. The cholesterol–HDL–glucose (CHG) index is a composite lipid–glucose index that may reflect metabolic dysfunction related to insuli...
Higher TyG and SUA levels, particularly their co-occurrence, were associated with prevalent advanced CKM, suggesting these biomarkers may characterize distinct but overlapping metabolic profiles relevant to CKM assessment.
Sheng-Zhu Huang, Jing-Wei Lin, Ling-Yu Ye et al.· Frontiers in Nutrition· 0 citations
Cardiovascular-kidney-metabolic (CKM) syndrome is a potential public health challenge characterized by overlapping cardiovascular, kidney, and metabolic disorders. Although insulin resistance-related surrogate indices have been linked to cardiometabolic outcomes, their prognostic value for incidence of cardiometabo...
Min Li, Chenfeng Luo, Dong-ying Liu et al.· Scientific Reports· 0 citations
Background The triglyceride-glucose (TyG) index and its derivatives are cost-effective markers of insulin resistance and cardiovascular risk. However, the comparative predictive value of baseline levels, cumulative exposure, and annual mean changes in TyG-related indices remains unclear. This study aimed to systematica...
Yang-Zhen Xue, Qing-Xiu Tian, Rong Zhang et al.· Frontiers in Endocrinology· 0 citations
Objective Data on the relationship between the triglyceride-glucose index/high-density lipoprotein cholesterol ratio (TyGHR) and diabetes mellitus (DM) onset remain limited. This study investigated the association between TyGHR and incident DM and assessed its predictive utility. Methods A total of 8,789 adults who rec...
Wangsheng Deng, Yonggang Yang, Jie Li et al.· Frontiers in Endocrinology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.